BPS2022
Drug discovery and design
基本信息
| 学分 | 6 credit points |
|---|---|
| 开课学期 | Second semester |
| 校区 | Malaysia |
| 考核构成 | Mid-semester test — 10% Final assessment — 50% Laboratory tasks — 15% Workshop submissions — 10% Case studies assignment — 15% |
开课安排1 条
| 教学期 | 授课方式 | 状态 |
|---|---|---|
| Second semester | Teaching activities are on-campus (ON-CAMPUS) | 开课 |
以上为该校区在官方资料中登记的全部开课安排，不是汇总。同一门课可能在多个 教学期开课，也可能不同教学期的授课方式不同。
课程简介
This unit will educate you on different approaches in drug discovery and design, using the typical pipeline of drug discovery and development as a foundation for your understanding. You will begin by examining how drug discovery and development has changed over the last 100 years, then move how to drug targets can be identified and validated. You will then look at how bioactive molecules can be discovered and how they can be further modified structurally to improve their performance as safe and effective therapeutics: The unit will guide you through various methods of discovery and development (including compound libraries, screening approaches, molecular modelling and structure-based drug design) both for small molecules and biologics. Lab classes will concentrate on developing a range of basic skills relevant to contemporary drug discovery. You will be able to test your newly-developed knowledge in a team environment by reporting on the discovery and development of a drug recently approved for human clinical use.
以上为 Monash Handbook 的官方原文，版权属 Monash University，此处按本站要求转载并标注出处： 官方页面 ↗
学习成果8 条
官方原文（Learning outcomes），版权属 Monash University。
- ULO1 Compare historical and contemporary approaches to drug discovery in the context of the drug discovery and development pipeline
- ULO2 Describe the principles and methods of target identification and validation, assessing their importance in drug discovery
- ULO3 Differentiate between target-based and phenotypic approaches to small-molecule discovery, including the libraries and screening assays that might be suitable for each approach
- ULO4 Calculate and interpret a range of drug-likeness parameters and assess their relevance in early-stage drug development
- ULO5 Describe and use basic computational molecular modelling approaches used in structure-based drug design
- ULO6 Describe the structures, approaches to the discovery, and applications of biologics, comparing them to those of typical small molecule drugs
- ULO7 Demonstrate fundamental chemical laboratory skills relevant to drug discovery, including compound synthesis, purification, and characterization
- ULO8 Investigate and critically analyze the discovery and development of a contemporary drug in a team setting
教学方式与预期工作量
教学方式
Case-based teaching
Enquiry-based learning
Problem-based learning
Online learning
Active learning
预期工作量
• 36 hours of online preparation modules (Discovery)
• Six 2-hour applied sessions (Q&A)
• Four 4-hour laboratories
• Six 2-hour workshops
• 8 hours of group/team work
• 60 hours of independent study
官方原文，版权属 Monash University。
先修 / 同修要求
官方资料未列出该课程的先修要求。
修完这门课可以衔接
先修链路
官方资料未列出该课程的先修要求，因此没有链路可画。
属于这些学位1 个
这门课出现在下列学位的官方结构里。反过来说：如果你读的是这些学位之一，它大概率是要修的 （必修还是选修取决于它在 Part 里的位置，点进去看结构）。
数据来源
- 数据来源
- 官方网页
handbook.monash.edu ↗ - 抓取时间
- 2026-09-13
- 可信度
- 程序抓取，未人工核实
查看官方完整描述 ↗ — 事实性字段（代码、学分、教学期、授课方式、考核权重、先修/同修/互斥关系）与 课程简介、学习成果、教学方式、预期工作量均取自官方 Handbook； 正文版权属 Monash University，此处转载并逐处标注出处。
发现信息有误？告诉我们。请用自己的话描述问题，不要上传成绩单、截图或校内系统文件。